BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36833093)

  • 1. Emerging Therapeutic Strategies for Diffuse Intrinsic Pontine Glioma: A Systematic Review.
    Farrukh S; Habib S; Rafaqat A; Sarfraz Z; Sarfraz A; Sarfraz M; Robles-Velasco K; Felix M; Cherrez-Ojeda I
    Healthcare (Basel); 2023 Feb; 11(4):. PubMed ID: 36833093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma.
    Arms LM; Duchatel RJ; Jackson ER; Sobrinho PG; Dun MD; Hua S
    J Control Release; 2024 Jun; 370():835-865. PubMed ID: 38744345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.
    Heiss JD; Jamshidi A; Shah S; Martin S; Wolters PL; Argersinger DP; Warren KE; Lonser RR
    J Neurosurg Pediatr; 2018 Dec; 23(3):333-342. PubMed ID: 30544335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
    DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M
    J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single institution experience in re-irradiation of biopsy-proven diffuse intrinsic pontine gliomas.
    Zamora PL; Miller SR; Kovoor JJ
    Childs Nerv Syst; 2021 Aug; 37(8):2539-2543. PubMed ID: 33973056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs.
    Rechberger JS; Lu VM; Zhang L; Power EA; Daniels DJ
    Childs Nerv Syst; 2020 Jan; 36(1):39-46. PubMed ID: 31489454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DIPG in Children - What Can We Learn from the Past?
    Vanan MI; Eisenstat DD
    Front Oncol; 2015; 5():237. PubMed ID: 26557503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
    Souweidane MM; Kramer K; Pandit-Taskar N; Zhou Z; Haque S; Zanzonico P; Carrasquillo JA; Lyashchenko SK; Thakur SB; Donzelli M; Turner RS; Lewis JS; Cheung NV; Larson SM; Dunkel IJ
    Lancet Oncol; 2018 Aug; 19(8):1040-1050. PubMed ID: 29914796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
    Gits HC; Anderson M; Stallard S; Pratt D; Zon B; Howell C; Kumar-Sinha C; Vats P; Kasaian K; Polan D; Matuszak M; Spratt DE; Leonard M; Qin T; Zhao L; Leach J; Chaney B; Escorza NY; Hendershot J; Jones B; Fuller C; Leary S; Bartels U; Bouffet E; Yock TI; Robertson P; Mody R; Venneti S; Chinnaiyan AM; Fouladi M; Gottardo NG; Koschmann C
    Acta Neuropathol Commun; 2018 Jul; 6(1):67. PubMed ID: 30049282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience of convection-enhanced delivery (CED) of carboplatin and sodium valproate into the pons for the treatment of diffuse intrinsic pontine glioma (DIPG) in children and young adults after radiotherapy.
    Szychot E; Walker D; Collins P; Hyare H; Shankar A; Bienemann A; Hollingworth M; Gill S
    Int J Clin Oncol; 2021 Apr; 26(4):647-658. PubMed ID: 33575829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a human in vitro blood-brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance.
    Deligne C; Hachani J; Duban-Deweer S; Meignan S; Leblond P; Carcaboso AM; Sano Y; Shimizu F; Kanda T; Gosselet F; Dehouck MP; Mysiorek C
    Fluids Barriers CNS; 2020 Jun; 17(1):37. PubMed ID: 32487241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.
    Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L
    Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment.
    Zhou Z; Singh R; Souweidane MM
    Curr Neuropharmacol; 2017; 15(1):116-128. PubMed ID: 27306036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.
    Sewing AC; Caretti V; Lagerweij T; Schellen P; Jansen MH; van Vuurden DG; Idema S; Molthoff CF; Vandertop WP; Kaspers GJ; Noske DP; Hulleman E
    J Neurosci Methods; 2014 Dec; 238():88-94. PubMed ID: 25263805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets.
    Aziz-Bose R; Monje M
    Curr Opin Oncol; 2019 Nov; 31(6):522-530. PubMed ID: 31464759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies.
    Liu G; Qiu Y; Zhang P; Chen Z; Chen S; Huang W; Wang B; Yu X; Guo D
    Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care.
    Williams JR; Young CC; Vitanza NA; McGrath M; Feroze AH; Browd SR; Hauptman JS
    Neurosurg Focus; 2020 Jan; 48(1):E4. PubMed ID: 31896081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
    Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
    Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma.
    Hashizume R
    Neurol Med Chir (Tokyo); 2017 Jul; 57(7):331-342. PubMed ID: 28592748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.